The governments of China, India, and the United Kingdom are unanimous in their belief that bioinformatics should supply the link between basic life sciences research and its translation into health benefits for the population and the economy. Yet at the same time, as ambitious states vying for position in the future global bioeconomy they differ considerably in the strategies adopted in pursuit of this goal. At the heart of these differences lies the interaction between epistemic change within the scientific community itself and the apparatus of the state. Drawing on desk-based research and thirty-two interviews with scientists and policy makers in the three countries, this article analyzes the politics that shape this interaction. From thi...
The book examines the evolution of one of the most important technologies that has emerged in the la...
Today, bioscientific research and commercialization are considered to be critical for improving a nu...
The argument refutes claims that China has in recent years fundamentally altered its stance on GMOs ...
The governments of China, India, and the United Kingdom are unanimous in their belief that bioinform...
Bioinformatics comprises a diffuse field of technologies, knowledges, databases and software for med...
<p>Abstract copyright data collection owner.</p>Interviews: Focusing on four case studies, the resea...
This article critiques the notion of a cross-national convergence of institutional and policy respon...
The rise of bioinformatics is a direct response to the political difficulties faced by genomics in i...
This article critiques the notion of a cross-national convergence of institutional and policy respon...
Stem cell science is a volatile political arena. Propelled by the scientific and economic promise of...
The role of the state in genomic innovation in relation to global life science competition is centra...
Despite the increasing advocacy towards the “openness” of science and research data, it is still far...
The book examines the evolution of a new industrial sector based on one of the most important techno...
About the book: Does the state still frame debates about new technology? Can policy-makers ensure th...
China is not only becoming a significant player in the production of high-tech products, but also an...
The book examines the evolution of one of the most important technologies that has emerged in the la...
Today, bioscientific research and commercialization are considered to be critical for improving a nu...
The argument refutes claims that China has in recent years fundamentally altered its stance on GMOs ...
The governments of China, India, and the United Kingdom are unanimous in their belief that bioinform...
Bioinformatics comprises a diffuse field of technologies, knowledges, databases and software for med...
<p>Abstract copyright data collection owner.</p>Interviews: Focusing on four case studies, the resea...
This article critiques the notion of a cross-national convergence of institutional and policy respon...
The rise of bioinformatics is a direct response to the political difficulties faced by genomics in i...
This article critiques the notion of a cross-national convergence of institutional and policy respon...
Stem cell science is a volatile political arena. Propelled by the scientific and economic promise of...
The role of the state in genomic innovation in relation to global life science competition is centra...
Despite the increasing advocacy towards the “openness” of science and research data, it is still far...
The book examines the evolution of a new industrial sector based on one of the most important techno...
About the book: Does the state still frame debates about new technology? Can policy-makers ensure th...
China is not only becoming a significant player in the production of high-tech products, but also an...
The book examines the evolution of one of the most important technologies that has emerged in the la...
Today, bioscientific research and commercialization are considered to be critical for improving a nu...
The argument refutes claims that China has in recent years fundamentally altered its stance on GMOs ...